Reduction of endothelial NOS and bradykinin-induced extravasation of macromolecules in skeletal muscle of the fructose-fed rat model

Cardiovascular Research

Volumn 59, Issue 4, 2003, Pages 963-970

  Plante, Gérard E ^a   Perreault, Mylène ^b   Lanthier, Alexis ^a   Marette, André ^b   Maheux, Pierre ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Capillaries; Diabetes; Endothelial function; Microcirculation; Regional blood flow

Indexed keywords

BRADYKININ; EOSIN; EVANS BLUE; FRUCTOSE; HEMATOXYLIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; EXTRAVASATION; IMMUNOREACTIVITY; MACROMOLECULE; MALE; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RAT; SKELETAL MUSCLE; TISSUE HOMOGENATE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD GLUCOSE; BRADYKININ; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; FRUCTOSE; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MODELS, ANIMAL; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY;

EID: 1642360931     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00521-2     Document Type: Article

References (38)

1. DeFronzo R.A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
2. Rett K. The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome. Diabetes Obes Metab. 1:(Suppl. 1):1999;S8-16.
3. Sowers J.R., Standley P.R., Ram J.L., et al. Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens. 6:1993;260S-270S.
4. Taylor A.A. Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus. Endocrinol Metab Clin North Am. 30:2001;983-997.
5. De Vriese A.S., Verbeuren T.J., Van de Voorde J., Lameire N.H., Vanhoutte P.M. Endothelial dysfunction in diabetes. Br J Pharmacol. 130:2000;963-974.
6. McVeigh G.E., Brennan G.M., Johnston G.D., et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia. 35:1992;771-776.
7. Tooke J.E. Microvascular function in human diabetes: A physiological perspective. Diabetes. 44:1995;721-726.
8. Hsueh W.A., Anderson P.W. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension. 20:1992;253-263.
9. Steinberg H.O., Chaker H., Leaming R., et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 97:1996;2601-2610.
10. Boegehold M.A. Heterogeneity of endothelial function within the circulation. Curr Opin Nephrol Hypertens. 7:1998;71-78.
11. Gerritsen M.E. Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol. 36:1987;2701-2711.
12. Chakir M., Plante G.E., Maheux P. Reduction of capillary permeability in the fructose-induced hypertensive rat may be responsible for the insulin resistance phenomenon. Am J Hypertens. 11:1998;563-569.
13. Levick J.R. Specialization in individual circulations. An introduction to cardiovascular physiology. 2nd ed:1995;236-238 Butterworth Heinemann, Oxford.
14. Tobey T.A., Mondon C.E., Zavaroni I., Reaven G.M. Mechanism of insulin resistance in fructose-fed rats. Metabolism. 31:1982;608-612.
15. Lee M.K., Miles P.D., Khoursheed M., et al. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes. 43:1994;1435-1439.
16. Bhanot S., McNeill J.H., Bryer-Ash M. Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats. Hypertension. 23:1994;308-312.
17. Sirois M.G., Plante G.E., Braquet P., Sirois P. Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways. Br J Pharmacol. 101:1990;896-900.
18. Plante G.E., Bissonnette M., Sirois M.G., Regoli D., Sirois P. Renal permeability alteration precedes hypertension and involves bradykinin in the spontaneously hypertensive rat. J Clin Invest. 89:1992;2030-2032.
19. 2 receptor activation elicits organ-specific increases in microvascular permeability in the rat. Am J Physiol. 268:1995;R366-R374.
20. Rogers D.F., Boschetto P., Barnes P.J. Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. J Pharmacol Methods. 21:1989;309-315.
21. O'Brien J.G., Battistini B., Farmer P., et al. Aprotinin, an antifibrinolytic drug, attenuates bradykinin-induced permeability in conscious rats via platelets and neutrophils. Can J Physiol Pharmacol. 75:1997;741-749.
22. van den Buuse M., Kerkhoff J. Interaction of bradykinin and angiotensin in the regulation of blood pressure in conscious rats. Gen Pharmacol. 22:1991;759-762.
23. 2- receptors mediate the pressor and renal hemodynamic effects of intravenous bradykinin in conscious rats. J Auton Nerv Syst. 75:1999;7-15.
24. Patterson C.E., Rhoades R.A., Garcia J.G. Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol. 72:1992;865-873.
25. Kapur S., Bédard S., Marcotte B., Côté C.H., Marette A. Expression of nitric oxide as a modulator of insulin action. Diabetes. 46:1997;1691-1700.
26. Hornig B., Drexler H. Endothelial function and bradykinin in humans. Drugs. 54:(Suppl. 5):1997;42-47.
27. Mombouli J.-V., Vanhoutte P.M. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol. 35:1996;679-705.
28. Kobzik L., Stringer B., Balligand J.L., Reid M.B., Stamler J.S. Endothelial type nitric oxide synthase in skeletal muscle fibers-mitochondrial relationships. Biochem Biophys Res Commun. 211:1995;375-381.
29. Segal S.S., Brett S.E., Sessa W.C. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters. Am J Physiol Heart Circ Physiol. 277:1999;H1167-1177.
30. Perreault M., Dombrowski L., Marette A. Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats. Diabetologia. 43:2000;427-437.
31. Grozdanovic Z. NO message from muscle. Microsc Res Tech. 55:2001;148-153.
32. Kiff R.J., Gardiner S.M., Compton A.M., Bennett T. Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol. 103:1991;1357-1362.
33. Meyer C., Dostou J.M., Welle S.L., Gerich J.E. Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab. 282:2002;E419-E427.
34. Clerk L.H., Rattigan S., Clark M.G. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes. 51:2002;1138-1145.
35. Baron A.D., Tarshoby M., Hook G., et al. Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes. 49:2000;768-774.
36. Yang Y.J., Hope I.D., Ader M., Bergman R.N. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am J Physiol Endocrinol Metabol. 266:1994;E17-E25.
37. Sjöstrand M., Gudbjörnsdottir S., Holmäng A., et al. Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects. Diabetes. 51:2002;2742-2748.
38. Wascher T.C., Wölkart G., Russell J.C., Brunner F. Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats. Diabetes. 49:2000;803-809.